ALTSTATION.IO

Verisk Analytics, Inc. (VRSK) Stock Analysis

By Nova Skye | AltStation.io | Updated October 25, 2026

Price
$196.40
Change
-3.41%
Market Cap
$25.73B
Avg Volume
1.3M

Company Overview

Founded in 1971 and headquartered in Jersey City, New Jersey, Verisk Analytics (VRSK) operates in the Industrials sector under Consulting Services, selling data analytics and software tools directly to the global insurance industry. Their core underwriting products supply property and auto rating rules, policy forms, prospective loss costs, and catastrophe risk models to help carriers price policies accurately. On the claims side, Verisk sells building repair estimating software, casualty workflow automation, and anti-fraud detection systems. Property, casualty, life, and reinsurance companies rely on these platforms to optimize risk selection, process claims, and curb fraud.

Verisk operates as an entrenched market leader in property and casualty insurance analytics, not an unproven challenger. Their edge comes from proprietary actuarial data, rating rules, and standardized policy forms built over five decades, creating high switching costs for carriers embedded in their ecosystem. The main risk to their business model is their tight dependence on the insurance sector, where carrier consolidation or underwriting pullbacks directly pressure software budgets. While specialized insurtech vendors challenge specific workflows, Verisk’s end-to-end integration across underwriting and claims keeps competitors at a distance.

The company stands firmly focused on its core insurance technology portfolio, scaling both international solutions and specialty reinsurance management. Growth centers on expanding catastrophe risk modeling, life insurance workflows, and automated claims processing across international motor and casualty franchises. By keeping their focus strictly on insurance analytics rather than diversifying into unrelated industries, Verisk prioritizes recurring enterprise software demand. They are a defensive, mission-critical vendor whose value depends directly on carrier adoption of advanced risk modeling.

Key Financials
Market Cap
$25.73B
Revenue
$3.14B
EBITDA
$1.52B
Gross Margin
70.2%
Profit Margin
28.2%
Revenue Growth
4.4%
Total Cash
$552.20M
Total Debt
$4.62B
Free Cash Flow
$1.06B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
30.17
Forward P/E
22.56
Beta
0.69
52-Week High
$236.54
52-Week Low
$155.94
EPS
$6.51
50-Day Avg
$180.36
200-Day Avg
$187.29
Price/Book
-21.50
VRSK 52-Week Stock Chart
Technical Analysis
VRSK trades at $196.40, roughly 52% of the way through its $155.10-to-$233.54 52-week range. The stock is 16.13% below its 52-week high and 26.29% above its 52-week low. Price is 9.78% above the 20-day moving average of $178.43, showing a sharp recent recovery. Momentum is positive at 2.61% over five trading days and 15.76% over 20 trading days. Near-term support sits at $163.28, while $203.33 is the resistance level buyers need to clear.


Recent News and Developments

Verisk officer files to sell 16,859 shares

Officer Nicholas Daffan filed a proposed sale of 16,859 VRSK shares valued at $3,249,748.78, with an approximate sale date of October 20. The shares include 15,827 from an employee stock-option exercise and 1,032 from restricted-stock vesting. Source: Stock Titan

Verisk and AccuLynx argue merger dispute before Delaware Supreme Court

The Delaware Supreme Court heard arguments on October 21 over whether Verisk engaged in “willful conduct” tied to its attempted termination of the AccuLynx acquisition. The court said it would try to issue a quick decision. Source: MLex

Delaware Supreme Court rejects Verisk’s AccuLynx appeal

The Delaware Supreme Court affirmed the Court of Chancery judgment on October 23, leaving Verisk obligated to keep pursuing its $2.35 billion AccuLynx acquisition. Verisk said the transaction still requires FTC review and customary closing conditions, so completion is not guaranteed. Source: Law360



Market Sentiment and Analyst Recommendations

Bull Case
Verisk generates $3.14 billion in revenue and is still growing, with revenue up 4.4%. The stock’s 15.76% gain over 20 trading days and position above the $178.43 moving average show buyers have returned. All 17 analysts covering VRSK rate it a buy. Their average target is $226.47, which is 15.31% above the current $196.40 price. The high target of $260.00 leaves more upside if execution improves, while $552.20 million in cash provides some financial flexibility. The case for buying here is straightforward: positive growth, strong momentum, and an analyst consensus that sees the stock trading higher.
Bear Case
A 30.17 P/E is demanding for a company growing revenue by 4.4%. Verisk also carries $4.62 billion in debt against $552.20 million in cash, limiting its room for error. The low analyst target is $195.00, slightly below the current $196.40 price, so not every valuation case offers upside. Verisk remains obligated to pursue the $2.35 billion AccuLynx acquisition after losing its October 23 appeal, creating financing and execution risk. The transaction still requires FTC review and customary closing conditions, so the company must keep pursuing a deal that is not guaranteed to close. Trading has also been unstable: a 5.71% rise to $203.33 on October 22 was followed by a 3.66% decline to $195.88 on October 23.
What to Watch
The biggest catalyst is the $2.35 billion AccuLynx acquisition following the Delaware Supreme Court’s October 23 decision. Investors should watch the FTC review because the transaction cannot be treated as complete while regulatory approval and customary closing conditions remain outstanding. Price action around $203.33 matters; a sustained move above that 30-day high would break the current resistance level. On the downside, losing the $178.43 moving average would weaken the recent momentum, while $163.28 is the key near-term support. Revenue growth also needs monitoring because 4.4% growth must support a 30.17 P/E valuation. Investors should also track whether Nicholas Daffan completes the proposed sale of 16,859 shares valued at $3,249,748.78 after the approximate October 20 sale date.
Analyst Consensus
BUY

Based on 17 analyst opinions
Low Target
$195.00
Mean Target
$226.47
High Target
$260.00


Earnings and Financial Data

Sector
Industrials
Industry
Consulting Services
Employees
8,000
Earnings & Dividends
Next Earnings
Nov 05, 2026
EPS (Trailing)
$6.51
Dividend Yield
98.0%
Payout Ratio
29.2%

Frequently Asked Questions

Is VRSK a good stock to buy?
VRSK has a buy recommendation from 17 analysts, positive 20-day momentum of 15.76%, and revenue growth of 4.4%. The takeaway is that the data supports a bullish view, but the 30.17 P/E demands continued execution.
What is VRSK’s price target?
The average analyst target is $226.47, with estimates ranging from $195.00 to $260.00. The takeaway is that the consensus target sits above the current $196.40 price, although the lowest target offers no meaningful upside.
How far is VRSK from its 52-week high?
VRSK is 16.13% below its technical 52-week high of $233.54. The takeaway is that the stock has recovery room but has not returned to its yearly peak.
What are VRSK’s support and resistance levels?
Near-term support is $163.28, based on the 30-day low, and resistance is $203.33, based on the 30-day high. The takeaway is that $203.33 is the immediate level buyers need to break.
Is VRSK overvalued?
VRSK trades at a P/E of 30.17 while revenue is growing 4.4%. The takeaway is that the valuation is expensive relative to the reported growth rate and leaves limited tolerance for weaker results.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated October 25, 2026.